top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

COUR Pharmaceuticals Secures $40M Upfront in Genentech Deal, Potential Milestones Exceed $900M

Dec 4, 2024
1 min read

Chicago, December 3, 2024 (Globe Newswire) -- COUR Pharmaceuticals and Genentech have partnered to develop novel autoimmune disease treatments using COUR's tolerogenic nanoparticle platform. COUR will earn $40 million upfront and may receive over $900 million in additional milestones and royalties. The collaboration combines COUR’s innovation with Genentech’s expertise in clinical development and commercialization.

Read full article here.

Recent Posts

Agilent to Acquire Biocare Medical in $950M Pathology Diagnostics Deal

Santa Clara, CA & San Francisco, CA, March 9, 2026 (Business Wire) -- Agilent Technologies announced it has agreed to acquire Biocare Medical for $950 million in cash, expanding its portfolio in cli

Qlaris Bio Appoints Fred Guerard as CEO

Dedham, MA, March 1, 2026 (Business Wire) -- Qlaris Bio has appointed Fred Guerard, Pharm.D., as president and chief executive officer, effective March 1, 2026, and he will also join the company’s b

Servier to Acquire Day One Biopharmaceuticals for $2.5B

Suresnes, France & Brisbane, CA, March 6, 2026 (Globe Newswire) -- Servier has agreed to acquire Day One Biopharmaceuticals for $21.50 per share in cash, representing a total equity value of approxi

Comments

Life Science Headlines

Agilent to Acquire Biocare Medical in $950M Pathology Diagnostics Deal

Qlaris Bio Appoints Fred Guerard as CEO

Servier to Acquire Day One Biopharmaceuticals for $2.5B

Coloplast Names Gavin Wood as CEO

Medtronic to Acquire Scientia Vascular in $550M Stroke-Care Deal

GSK to Pay $950M for Pulmonary Hypertension Drug Aimed at Reducing Bleeding Risk

LIXTE Names Sidney Braun CEO of Liora Technologies

Korsana Biosciences Raises $175M to Advance Next-Generation Alzheimer’s Antibody

Belén Garijo to Lead Sanofi as CEO

Danaher Corporation to Acquire Masimo Corporation for $9.9B

bottom of page